Skip to Content
Merck
CN
  • T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma.

T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma.

Cancer immunology research (2017-10-27)
Ingunn M Stromnes, Ayaka Hulbert, Robert H Pierce, Philip D Greenberg, Sunil R Hingorani
ABSTRACT

Pancreatic ductal adenocarcinoma (PDA) is a lethal malignancy resistant to most therapies, including immune checkpoint blockade. To elucidate mechanisms of immunotherapy resistance, we assessed immune parameters in resected human PDA. We demonstrate significant interpatient variability in T-cell number, localization, and phenotype. CD8

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Monoclonal Anti-Cytokeratin, pan−FITC antibody produced in mouse, clone C-11, purified immunoglobulin, buffered aqueous solution